Masahiro Kanayama
Omorinaka, 1438541, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Host Immunity Influences the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients.
Journal: Hepato-gastroenterology
Published: May 01, 2014
Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Journal: Cancer chemotherapy and pharmacology
Published: February 10, 2014
Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy.
Journal: Hepato-gastroenterology
Published: June 05, 2013
Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report.
Journal: Oncology letters
Published: April 25, 2013
Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib.
Journal: Cancer chemotherapy and pharmacology
Published: March 27, 2013
A case of sclerosing angiomatoid nodular transformation of the spleen: correlations between contrast-enhanced ultrasonography and histopathologic findings.
Journal: Journal of clinical ultrasound : JCU
Published: August 10, 2012
A case of poorly differentiated hepatocellular carcinoma with intriguing ultrasonography findings.
Journal: Oncology letters
Published: March 06, 2012
Duct of Luschka diagnosed by sonography in a patient with bile duct carcinoma and intrahepatic bile duct dilatation.
Journal: Journal of clinical ultrasound : JCU
Published: February 17, 2012
Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma.
Journal: Clinical & developmental immunology
Published: December 26, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026